Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Craniometrix
AddedFeb 15, 2024
UpdatedJun 18, 2026
Craniometrix

Craniometrix

Seed

Creating a one-stop Alzheimer's care platform for easier monitoring and support.

HQ
New York City, NY, US
Founded
2021
Accelerator
Y Combinator logoY CombinatorW22
Overview
Compare
Fundraising
Employees
Website

Craniometrix is dedicated to revolutionizing Alzheimer's care through its comprehensive platform designed to simplify and enhance the caregiving process. The company offers a dementia care navigation platform that leverages AI-powered software and highly-trained social workers to support caregivers and healthcare providers. By focusing on critical aspects such as memory issues, depression, fall risk, and home safety, Craniometrix aims to improve the quality of life for both patients and their caregivers.

Craniometrix has achieved significant milestones, including raising over $6 million in funding to advance its mission. The platform has demonstrated tangible benefits, such as delaying nursing home placement and improving caregiver quality of life. Additionally, Craniometrix's GUIDE program ensures frequent patient touchpoints and compliance, leading to increased annual profits for participating healthcare providers. These accomplishments underscore the company's impact in the Alzheimer's care landscape.

Craniometrix - Similar Companies

MyndYou logo

MyndYou

myndyou.com

Synapticure logo

Synapticure

synapticure.com

ExaCare logo

ExaCare

exacare.com

SafelyYou logo

SafelyYou

safely-you.com

Cogniant.co logo

Cogniant.co

cogniant.co

ConnectCareHero logo

ConnectCareHero

Cerebro Solutions logo

Cerebro Solutions

Osmind logo

Osmind

osmind.org

BrainKey logo

BrainKey

brainkey.ai

Azra Care logo

Azra Care

azra.ai

OndeCare logo

OndeCare

ondecare.com

Frame Health logo

Frame Health

framehealth.com

Handl Health logo

Handl Health

gohandlhealth.com

Auricle logo

Auricle

auricle.com

Aiva logo

Aiva

aiva.ai

Craniometrix - Quick Facts

Who are Craniometrix's competitors?

Companies similar to Craniometrix include MyndYou, Synapticure, ExaCare and SafelyYou.

When was Craniometrix founded?

Craniometrix was founded in 2021.

Where is Craniometrix's headquarters located?

Craniometrix's headquarters is located in New York City, NY, US.

When was Craniometrix's last funding round?

Craniometrix's most recent funding round was for $6M (USD) in August 2022.

How much has Craniometrix raised to-date?

As of Aug 10, 2022, Craniometrix has raised a total of $6M (USD).

How many employees does Craniometrix have?

Craniometrix has 5 employees as of Mar 12, 2024.

Craniometrix - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Care Platform
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software